Central Trust Company’s Orexigen Therapeutics, Inc. OREX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-200
| Closed | – | – | 1438 |
|
|
2017
Q2 | $0 | Hold |
200
| – | – | ﹤0.01% | 1379 |
|
|
2017
Q1 | $0 | Hold |
200
| – | – | ﹤0.01% | 1262 |
|
|
2016
Q4 | $0 | Hold |
200
| – | – | ﹤0.01% | 1246 |
|
|
2016
Q3 | $0 | Hold |
200
| – | – | ﹤0.01% | 1244 |
|
|
2016
Q2 | $0 | Hold |
200
| – | – | ﹤0.01% | 1214 |
|
|
2016
Q1 | $1K | Hold |
200
| – | – | ﹤0.01% | 1105 |
|
|
2015
Q4 | $3K | Hold |
200
| – | – | ﹤0.01% | 1117 |
|
|
2015
Q3 | $4K | Hold |
200
| – | – | ﹤0.01% | 1117 |
|
|
2015
Q2 | $10K | Hold |
200
| – | – | ﹤0.01% | 1016 |
|
|
2015
Q1 | $16K | Hold |
200
| – | – | ﹤0.01% | 903 |
|
|
2014
Q4 | $12K | Hold |
200
| – | – | ﹤0.01% | 953 |
|
|
2014
Q3 | $9K | Hold |
200
| – | – | ﹤0.01% | 1011 |
|
|
2014
Q2 | $12K | Buy |
+200
| New | +$12K | ﹤0.01% | 944 |
|